<DOC>
	<DOCNO>NCT00420992</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Kadian NT ( ALO-01 ) compare placebo treat moderate severe chronic pain 12 week period .</brief_summary>
	<brief_title>A Study Embeda ( Kadian NT , ALO-01 ) Subjects With Pain Due Osteoarthritis Hip Knee</brief_title>
	<detailed_description>The primary objective study evaluate efficacy ALO-01 compare placebo treatment chronic moderate severe pain ( focus osteoarthritis hip knee ) measure mean change diary Brief Pain Inventory ( BPI ) score average pain ( daily score average pain averaged 7 day ) randomization 12 week follow randomization .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Subject 21 year age old Subject either childbearing potential OR subject must use acceptable method birth control childbearing potential Negative pregnancy test female childbearing potential Subject general good health Subject require treatment joint pain within last 90 day Subject primary diagnosis osteoarthritis ( OA ) hip knee Subject document history allergic reaction intolerance morphine opioids Subject pregnant breastfeeding Subject receive systemic chemotherapy Subject history drug abuse/dependence/misuse alcohol abuse/dependence Subject history major depressive disorder control medication Subject chronic pain syndrome ( i.e. , fibromyalgia ) may interfere symptom OA Subject active gastrointestinal disease , exception gastroesophageal reflux disease ( GERD ) Subject document history rheumatoid arthritis , uncontrolled inflammatory arthritis nonsteroidal antiinflammatory drug ( NSAID ) dependent inflammatory arthritis</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>hip</keyword>
	<keyword>knee</keyword>
	<keyword>pain</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>OA</keyword>
	<keyword>Kadian</keyword>
	<keyword>Alpharma</keyword>
	<keyword>naltrexone</keyword>
	<keyword>Opioid</keyword>
	<keyword>morphine</keyword>
	<keyword>Embeda</keyword>
	<keyword>ALO-01</keyword>
</DOC>